Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
18.6M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
1.19M
-
Shares change
-
+67K
-
Total reported value, excl. options
-
$991K
-
Value change
-
+$38.2K
-
Number of buys
-
6
-
Number of sells
-
-2
-
Price
-
$0.83
Significant Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q2 2022
14 filings reported holding UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share as of Q2 2022.
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.19M shares
of 18.6M outstanding shares and own 6.42% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (730K shares), Board of Trustees of The Leland Stanford Junior University (248K shares), Ayrton Capital LLC (76.6K shares), GEODE CAPITAL MANAGEMENT, LLC (26.1K shares), VANGUARD GROUP INC (22.7K shares), Frontier Wealth Management LLC (18.8K shares), FineMark National Bank & Trust (15.6K shares), TANDEM CAPITAL MANAGEMENT CORP /ADV (15.5K shares), CITADEL ADVISORS LLC (15.2K shares), and RENAISSANCE TECHNOLOGIES LLC (11K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.